NDC 80425-0182-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0182
- Requested NDC
- 80425-0182-01
- Package NDCs from labels
- 80425-0182-1, 80425-0182-2, 80425-0182-3, 80425-0182-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0182-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 4 | |
| 80425-0182-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 4 | |
| 80425-0182-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0182 | GABAPENTIN CAPSULE [ADVANCED RX OF TENNESSEE, LLC] | 4 | Current NDC, Legacy NDC, 3 package rows | 20250108_d294f6aa-ed82-90a2-e053-2995a90a2896.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0182-1 | EA - Each | 80425-0182 | dde0e991-68db-4282-9f91-eeaeaec43ec1 | 1 | 2023-04-07 |
| 80425-0182-2 | EA - Each | 80425-0182 | 959247f2-5463-4cfb-946e-199b9716f8b9 | 1 | 2023-04-07 |
| 80425-0182-3 | EA - Each | 80425-0182 | 7738a8d1-bc15-4e12-9c36-61aec217e282 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | DIRECT RX | 29a70e2d-d3fd-4e32-95dd-7ee721d87388 | 2026-01-08 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| gabapentin | GABAPENTIN | Coupler LLC | 47cd25f6-e123-9aaf-e063-6394a90aeedd | 2026-01-07 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABARONE | GABAPENTIN | INA Pharmaceutics Inc. | 0f350a4b-f294-4b98-b69f-3cc789e930ba | 2026-01-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ajenat Pharmaceuticals LLC | 02304deb-7b4a-452f-9b1a-64ca0aedbcc2 | 2025-12-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Northwind Health Company, LLC | 471b2d32-0cbd-aade-e063-6394a90a1696 | 2025-12-29 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | ST. MARY'S MEDICAL PARK PHARMACY | 3aaf3d6e-c6d5-89f5-e063-6394a90a9b77 | 2025-12-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Northwind Health Company, LLC | 47214c7c-ba1b-9107-e063-6294a90a5431 | 2025-12-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | BioComp Pharma, Inc. | 0b3a4009-42f3-c84f-e063-6294a90a8068 | 2025-12-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | b86c81d9-9a4a-4847-be18-520e5cc5dc4b | 2025-12-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | JVET PHARMACEUTICALS LLC | 63a5fc6d-ca57-4726-b70d-805ac023d959 | 2025-12-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Glenmark Pharmaceuticals Inc., USA | 3865a6e3-112c-490c-82ac-35401336b16e | 2025-12-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 021329d0-7d32-4fd8-81bf-a8b0d8b49e43 | 2025-12-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Redpharm Drug | 44f2b497-55b2-864f-e063-6294a90ad6d5 | 2025-12-02 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 4470a567-93a6-a293-e063-6394a90affc1 | 2025-11-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b74a427c-9cc1-4b15-9ed2-cc891741fe67 | 2025-11-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Acella Pharmaceuticals, LLC | 3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2 | 2025-11-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 5134369d-c7f6-4569-a425-d50e5a5d694f | 2025-10-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 47a22de2-ec66-45be-8648-89ed3ab6e67e | 2025-10-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 25befbfa-5125-4363-8306-f862e81c0a6f | 2025-10-28 | Warnings, Adverse reactions | ANDA204989 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d9d78138-e1e9-4107-9099-4910cb1422d8 | 2025-10-22 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.